Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,471 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of renal functional outcomes of active surveillance and partial nephrectomy in the management of oncocytoma.
Meagher MF, Lane BR, Capitanio U, Mehrazin R, Bradshaw AW, Noyes S, Larcher A, Eldefrawy A, Ghali F, Patel D, Bruinius J, Dutt R, Keiner C, Miller N, Wan F, Montorsi F, Derweesh IH. Meagher MF, et al. Among authors: wan f. World J Urol. 2021 Apr;39(4):1195-1201. doi: 10.1007/s00345-020-03299-5. Epub 2020 Jun 17. World J Urol. 2021. PMID: 32556559
Comparison of retroperitoneal and transperitoneal robotic partial nephrectomy for Pentafecta perioperative and renal functional outcomes.
Stroup SP, Hamilton ZA, Marshall MT, Lee HJ, Berquist SW, Hassan AS, Beksac AT, Field CA, Bloch A, Wan F, McDonald ML, Patel ND, L'Esperance JO, Derweesh IH. Stroup SP, et al. Among authors: wan f. World J Urol. 2017 Nov;35(11):1721-1728. doi: 10.1007/s00345-017-2062-0. Epub 2017 Jun 27. World J Urol. 2017. PMID: 28656359
Should partial nephrectomy be considered "elective" in patients with stage 2 chronic kidney disease? A comparative analysis of functional and survival outcomes after radical and partial nephrectomy.
Hamilton ZA, Capitanio U, Lane BR, Larcher A, Yim K, Dey S, Cotta BH, Meagher MF, Kirmiz S, Bezinque A, Eldefrawy A, Bradshaw A, Ryan S, Carenzi C, Wan F, Proudfoot J, Montorsi F, Derweesh IH. Hamilton ZA, et al. Among authors: wan f. World J Urol. 2019 Nov;37(11):2429-2437. doi: 10.1007/s00345-019-02650-9. Epub 2019 Feb 1. World J Urol. 2019. PMID: 30710156
Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria.
Hamilton ZA, Capitanio U, Pruthi D, Ghali F, Larcher A, Patel DN, Eldefrawy A, Patel S, Cotta BH, Bradshaw AW, Meagher MF, Miller NS, Carenzi C, Wan F, Liss MA, McGregor T, Montorsi F, Derweesh IH. Hamilton ZA, et al. Among authors: wan f. Urology. 2020 Apr;138:60-68. doi: 10.1016/j.urology.2019.11.036. Epub 2019 Dec 11. Urology. 2020. PMID: 31836465
Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis.
Patel SH, Uzzo RG, Larcher A, Peyronnet B, Lane BR, Pruthi D, Reddy M, Capitanio U, Joshi S, Noyes S, Eldefrawy A, Ghali F, Meagher MF, Hamilton ZA, Yim K, Nasseri R, Bradshaw AW, Dey S, Kirmiz S, Wan F, Liss MA, Bensalah K, Montorsi F, Derweesh IH. Patel SH, et al. Among authors: wan f. Clin Genitourin Cancer. 2020 Dec;18(6):e723-e729. doi: 10.1016/j.clgc.2020.05.002. Epub 2020 May 11. Clin Genitourin Cancer. 2020. PMID: 32600941
Elevated preoperative C-reactive protein is associated with renal functional decline and non-cancer mortality in surgically treated renal cell carcinoma: analysis from the INternational Marker Consortium for Renal Cancer (INMARC).
Cotta BH, Meagher MF, Patil D, Saito K, Patel SH, Patel DN, Miller N, Dutt R, Keiner C, Bradshaw AW, Wan F, Eldefrawy A, Yasuda Y, Fujii Y, Master V, Derweesh IH. Cotta BH, et al. Among authors: wan f. BJU Int. 2021 Mar;127(3):311-317. doi: 10.1111/bju.15200. Epub 2020 Nov 19. BJU Int. 2021. PMID: 32772468
Evaluation of the association of health care system access with kidney cancer surgical outcomes for hispanic and non-hispanic white patients.
Javier-DesLoges JF, Meagher MF, Walia A, Nguyen MV, Perry JM, Narasimhan RS, Hakimi K, Soliman S, Yuan J, Chakoumakos MA, Ghali F, Patel DN, Wan F, Murphy JD, Derweesh IH. Javier-DesLoges JF, et al. Among authors: wan f. Urol Oncol. 2021 Dec;39(12):837.e1-837.e7. doi: 10.1016/j.urolonc.2021.08.021. Epub 2021 Sep 25. Urol Oncol. 2021. PMID: 34580026
Disparities in Cancer Specific and Overall Survival Outcomes in African Americans With Renal Cell Carcinoma: Analysis From the International Marker Consortium for Renal Cancer (INMARC).
Meagher MF, Patil D, Saito K, Javier-Desloges JF, Bradshaw AW, Patel SH, Cotta BH, Yasuda Y, Eldefrawy A, Ghali F, Nasseri R, Wan F, Fujii Y, Master V, Derweesh IH. Meagher MF, et al. Among authors: wan f. Urology. 2022 May;163:164-176. doi: 10.1016/j.urology.2021.12.022. Epub 2022 Jan 5. Urology. 2022. PMID: 34995562
Association of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and De Ritis ratio with mortality in renal cell carcinoma: A multicenter analysis.
Keiner C, Meagher M, Patil D, Saito K, Walia A, Liu F, Dutt R, Miller N, Dhanji S, Saidian A, Wan F, Yasuda Y, Fujii Y, Tanaka H, Master V, Derweesh I. Keiner C, et al. Among authors: wan f. Front Oncol. 2022 Nov 24;12:995991. doi: 10.3389/fonc.2022.995991. eCollection 2022. Front Oncol. 2022. PMID: 36505802 Free PMC article.
1,471 results